Online Store Catalog Donate Join NADD Contact Us Login Return to thenadd.org
Committees Leadership
Articles

Shopping

Guest
Merchandise Details
ST18-2021C Role of the Interdisciplinary Team when Psychotropic Medications are Used
Member Price$14.95
Non-Member Price$18.95
Merchandise Description

The topic of this webinar is the interface between the interdisciplinary team and the prescribing provider when psychotropic medications are used to manage psychiatric conditions. 

  • We will first discuss the various roles and contributions of the members of the interdisciplinary team at the initial evaluation/assessment needed to help establish the most accurate diagnosis possible. 
  • We will then explore a brief and general overview of various medication classes, what disorder/s they are commonly used to treat, and practical "real world" information about monitoring for symptom improvement and side effects.  
  • Finally, we will return to the interdisciplinary team's involvement in follow-up visits with the prescriber.

Dr. Thomas Scheidemantel, MD is a Senior Instructor in the Department of Psychiatry at the Case Western Reserve University School of Medicine.  Dr. Scheidemantel’s clinical practice focuses on adults, including older adults, who have an intellectual or developmental disability as well as co-occurring psychiatric or mental health needs.  Dr. Scheidemantel completed his undergraduate training at John Carroll University in Cleveland, Ohio and completed his undergraduate medical training at the Northeast Ohio Medical University in Rootstown, Ohio.  He completed his residency training in adult psychiatry at University Hospitals Cleveland Medical Center.  During residency Dr. Scheidemantel pursued additional training experience in medical genetics, as well as integrated care models within clinics at MetroHealth in Cleveland as well as Nationwide Children’s Hospital in Columbus specializing in the treatment of children and adults with developmental disabilities and complex healthcare needs.  Dr. Scheidemantel is involved in several research projects, including investigating treatment for early-onset cognitive problems in young adults with Down syndrome, and he has additional interests in medical ethics.